Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044031
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
2002-08-16
Brief Title:
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
Sponsor:
Cancer Advances Inc
Organization:
Cancer Advances Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02
Start Date Type:
None
Primary Completion Date:
2004-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-08-16
First Submit QC Date:
August 19 2002
Study First Post Date:
2002-08-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-16
Last Update Post Date:
2014-04-17
Last Update Post Date Type:
ESTIMATED